K Cheng et al. JPGN 2020; 71: 452-458. Cholangitis in Patients With Biliary Atresia Receiving Hepatoportoenterostomy: A National Database Study
This study, which relied on data from a pediatric database (PHIS) with 48 pediatric centers, identified 1112 subjects with biliary atresia (2004-2013).
- Median age at time of Kasai (hepatoportoenterostomy) procedure: 63 days
- Median number of admissions for cholangitis within 2 years was 2 episodes. The presence of portal hypertension (OR 2.24) and black race (OR 1.51) were associated with higher risk of cholangitis
- When Kasai was performed at >90 days, this lowered the likelihood of cholangitis (OR 0.46)
- With regards to those with 5 or more bouts of cholangitis, risk factors included Asian ethnicity (OR 2.66), public insurance (OR 1.72), and portal hypertension (OR 2.88)
- 56% of patients had portal hypertension and 15.6% had esophageal varices
- Neither steroids nor ursodeoxycholic acid were found to affect patient outcome
- Limitations: lack of clear definition for cholangitis diagnosis and episodes of cholangitis may not have been captured if patients received care outside the participating centers
My take: Cholangitis is a common problem following hepatoportoenterostomy. Earlier diagnosis of biliary atresia provides the best opportunity for improving long-term outcomes.
Related blog posts:
- Useful Data (2020) on Cholangitis Following Kasai Procedure for Biliary Atresia
- Landmark Study on Universal Screening for Biliary Atresia -It Works!
- Biliary Atresia and Bile Lakes
- Outcomes of “Successful” Biliary Atresia Patients
- Bad News Bili | gutsandgrowth
- Outcomes of Biliary Atresia | gutsandgrowth
- START Study: Steroids Not Effective For Biliary Atresia (After …
- What is the role for preventing variceal bleeding in Biliary …
- Learning a lot from ChiLDREN (part 1) | gutsandgrowth
- Learning a lot from ChiLDREN (part 2) | gutsandgrowth
Disclaimer: This blog, gutsandgrowth, assumes no responsibility for any use or operation of any method, product, instruction, concept or idea contained in the material herein or for any injury or damage to persons or property (whether products liability, negligence or otherwise) resulting from such use or operation. These blog posts are for educational purposes only. Specific dosing of medications (along with potential adverse effects) should be confirmed by prescribing physician. Because of rapid advances in the medical sciences, the gutsandgrowth blog cautions that independent verification should be made of diagnosis and drug dosages. The reader is solely responsible for the conduct of any suggested test or procedure. This content is not a substitute for medical advice, diagnosis or treatment provided by a qualified healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a condition.